For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Omega-3 Supplement | Two grams of the EPA form of omega-3 plus 50 mg of sertraline daily for 10 weeks Omega-3 supplement: Two grams of the EPA form of omega-3 daily and 50 mgs of sertraline daily for 10 weeks | 0 | None | 0 | 71 | 35 | 71 | View |
| Placebo | Two grams of corn oil plus 50 mg of sertraline daily for 10 weeks. Placebo: Two grams of corn oil plus 50 mg of sertraline daily for 10 weeks. | 0 | None | 0 | 73 | 32 | 73 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Insomnia | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Increased flatulence | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Increased sleepiness | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Dizziness | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Nausea | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Diarrhea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Constipation | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Hand Tremors | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Decreased sexual interest/performance | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Less emotionally responsive | SYSTEMATIC_ASSESSMENT | Social circumstances | None | View |
| Headaches | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Increased anxiety | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Agitation | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Increased sweating | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Decreased appetite | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Bad taste in mouth | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Burping | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |